N-terminal-pro-brain natriuretic peptide as a haemodynamic marker in idiopathic pulmonary arterial hypertension

Souza R., Bogossian H. B., Humbert M., Jardim C., Rabelo R., Amato M. B. P., Carvalho C. R. R.

Source: Eur Respir J 2005; 25: 509-513
Journal Issue: March
Disease area: Pulmonary vascular diseases

Congress or journal article abstractPDF journal article, handout or slidesFull text journal article

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Souza R., Bogossian H. B., Humbert M., Jardim C., Rabelo R., Amato M. B. P., Carvalho C. R. R.. N-terminal-pro-brain natriuretic peptide as a haemodynamic marker in idiopathic pulmonary arterial hypertension. Eur Respir J 2005; 25: 509-513

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Disproportionate elevation of N-terminal pro-brain natriuretic peptide in scleroderma-related pulmonary hypertension
Source: Eur Respir J 2010; 35: 95-104
Year: 2010



Can brain natriuretic peptide (BNP) be a predictor for pulmonary arterial hypertension?
Source: Annual Congress 2007 - Pulmonary hypertension: diagnosis and treatment
Year: 2007



Identification of left ventricular systolic dysfunction or pulmonary hypertension in patients with asthma or chronic obstructive pulmonary disease by N-terminal pro-brain natriuretic peptide
Source: Annual Congress 2007 - New insight into the pathophysiology of asthma
Year: 2007


N-terminal pro-brain natriuretic peptide is a useful prognostic marker in patients with pulmonary hypertension and renal insufficiency
Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I
Year: 2013


Association of haemodynamic parameters with circulating natriuretic peptides in precapillary pulmonary hypertension
Source: International Congress 2015 – Pulmonary hypertension: the right ventricle and its load
Year: 2015

Brain natriuretic peptides in patients with idiopathic pulmonary hypertension and chronic thromboembolic disease
Source: Annual Congress 2007 - Venous thromboembolic disease
Year: 2007


The diagnostic value of N-terminal pro-C-type natriuretic peptide in COPD patients with pulmonary hypertension
Source: International Congress 2015 – Pulmonary hypertension in lung disease
Year: 2015


Inhalation of vasoactive intestinal peptide in pulmonary hypertension
Source: Eur Respir J 2008; 32: 1289-1294
Year: 2008



Biomarkers in pulmonary hypertension
Source: Eur Respir J 2008; 32: 503-512
Year: 2008



N-terminal pro-brain natriuretic peptide in patients with acute pulmonary embolism
Source: Eur Respir J 2003 Oct 01;22(4):649-653
Year: 2003



Endothelin-1 and endothelin-3 plasma levels in severe idiopathic pulmonary arterial hypertension
Source: Annual Congress 2005 - Pulmonary hypertension: pathophysiology
Year: 2005


Role of brain natriuretic peptide levels in predicting the acute clinical worsening episodes and response to iloprost infusion in patients with pulmonary arterial hypertension
Source: Annual Congress 2009 - Pulmonary circulation I
Year: 2009


Brain natriuretic peptide in patients with acute pulmonary embolism
Source: Eur Respir J 2005; 26: Suppl. 49, 270s
Year: 2005

Brain natriuretic peptide and exercise capacity in lung fibrosis and pulmonary hypertension
Source: Eur Respir J 2004; 24: Suppl. 48, 111s
Year: 2004

Prognostic factors of acute heart failure in patients with pulmonary arterial hypertension
Source: Eur Respir J 2010; 35: 1286-1293
Year: 2010



Patients with primary or thromboembolic pulmonary hypertension develop renal resistance to ANP and BNP
Source: Eur Respir J 2003; 22: Suppl. 45, 463s
Year: 2003

Plasma big-endothelin and hemodynamics in patients with pulmonary arterial hypertension compared to patients with chronic left heart failure with and without pulmonary venous hypertension
Source: Annual Congress 2009 - Pulmonary circulation I
Year: 2009

Acute vasodilator response in different forms of pre-capillary pulmonary hypertension
Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment
Year: 2013

A point-of-care brain natriuretic peptide assay in the risk stratification and management of patients with pulmonary arterial hypertension
Source: Eur Respir J 2006; 28: Suppl. 50, 48s
Year: 2006

Apelin improves cardiac output in patients with pulmonary arterial hypertension
Source: International Congress 2015 – Pulmonary hypertension: novel clinical insights
Year: 2015